Effect of 5g messages on medication adherence and chemotherapy toxicity of patients with lung cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058188

Enrollment

Unknown

Registered

2022-04-01

Start date

2022-05-01

Completion date

Unknown

Last updated

2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication adherence

Interventions

Control group:General medication education

Intervention Group:Medication education based on 5G information

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients were diagnosed with lung cancer who need pemetrexed treatment; 2. Patients are with the ability to receive and read 5g messages.

Exclusion criteria

Exclusion criteria: 1. Patients don't have smart phones; 2. Patients were unwilling to accept the trial.

Design outcomes

Primary

Measure	Time frame
Medication adherence;Hematotoxicity / non-hematotoxicity index;	—

Secondary

Measure	Time frame
Serum concentrations of folic acid and vitamin B12;	—

Countries

China

Contacts

Public ContactChenxu Ni

Shanghai Tenth People's Hospital

nichenxu@126.com+86 134524506143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026